Identifying Methylation Biomarkers for Monitoring Bladder Tumors
Sponsor
Copenhagen University Hospital at Herlev (Other)
Overall Status
Unknown status
CT.gov ID
NCT00244205
Collaborator
(none)
120
1
Study Details
Study Description
Brief Summary
To investigate the methylation status of 4-6 genes in Urine and matching bladder tissue biopsies, in order to find methylation markers for use in a noninvasive test in monitoring patients with bladder tumors.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Using PCR Technology (Polymerase Chain Reaction Technology) for Monitoring Patients With Bladder Tumors - Optimizing Genanalyses for Clinical Use.
Study Start Date
:
Nov 1, 2005
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Patients with bladder tumors and patients with benign urinary tract conditions with no clinical suspicion of bladder cancer.
Exclusion Criteria:
- Patients with competing urinary and systemic diseases, pregnant and patients under 18 years of age.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Copenhagen University Hospital at Herlev | Herlev | Copenhagen | Denmark | 2730 |
Sponsors and Collaborators
- Copenhagen University Hospital at Herlev
Investigators
- Principal Investigator: Reza R Serizawa, MD, Copenhagen University Hospital at Herlev
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00244205
Other Study ID Numbers:
- Blæretumor PCR projekt
First Posted:
Oct 26, 2005
Last Update Posted:
Nov 15, 2005
Last Verified:
Nov 1, 2005
Additional relevant MeSH terms: